Home>Topics>Companies>Quest Diagnostics

Quest Diagnostics DGX

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
    1. Quest Diagnostics declares $0.33 dividend

      Headlines

      Fri, 15 Aug 2014

      Quest Diagnostics Incorporated (NYSE: DGX ) declares $0.33/share quarterly dividend , in line with previous. Forward yield 2.19% Payable Oct. 22; for shareholders of record Oct. 7; ex-div Oct. 3. Post your comment!

    2. New Morningstar Analyst Report for VCA Inc

      Stock Reports

      Thu, 24 Jul 2014

      forward. We note that various peripheral competitors have made noise about entering the reference lab area, including Quest Diagnostics and Abaxis. If any of these entities gain scale in the market, it could temper VCA's growth and margins. We

    3. Quest Diagnostics' ( DGX ) CEO Stephen Rusckowski on Q2 2014 Results - Earnings Call Transcript

      Headlines

      Thu, 24 Jul 2014

      Quest Diagnostics Inc (NYSE: DGX ) Q2 2014 Earnings Conference Call July 24, 2014 8:30 AM ET Executives ..... Presentation Operator Thank you for standing by and welcome to the Quest Diagnostics ’ Second Quarter 2014 Conference Call. At the request of

    4. Quest narrows guidance after Q2 results

      Headlines

      Thu, 24 Jul 2014

      Quest Diagnostics (NYSE: DGX ) Q2 results : Net Revenues: $1,902M (+4.8%); Cost of Services: $1,174M (+7.3%); SG&A Expense: $440M

    5. Quest Sees Slight Volume Gain in Second Quarter, but Also Faces Price Decline

      Commentary

      Thu, 24 Jul 2014

      Quest Diagnostics released second-quarter performance ..... organic volume growth remains lackluster at Quest . On one hand, quarterly organic volume ..... quarters of declines. On the other hand, Quest continues to trail its main rival LabCorp

    6. Raising Fair Value on Sonic Healthcare to Reflect Growing Offshore Presence

      Commentary

      Wed, 11 Jun 2014

      are reimbursed under Medicare and Medicaid respectively. In the U.S., Sonic remains a minnow compared with Quest Diagnostics and LabCorp, with a market share of about 1.5% versus 15%. The U.S. market remains attractive given expected

    7. Top 10 Purchases and Sales from Our Ultimate Stock-Pickers

      Headlines

      Tue, 3 Jun 2014

      was with Oakmark Equity & Income's elimination of Quest Diagnostics DGX "> DGX . Clyde McGregor noted the following in his ..... and three that didn’t (Encana, Hospira and Quest Diagnostics )... In the case of Encana and Quest Diagnostics

    8. LabCorp's First-Quarter Volume Was Solid, but Pricing Took a Hit

      Commentary

      Mon, 28 Apr 2014

      molecular pathology codes and sequestration. As with Quest Diagnostics , we anticipate the pressure should lift somewhat now ..... believe this sets LabCorp apart from its largest rival Quest . LabCorp is on the cusp of rolling out its Beacon LBS

    9. Quest Diagnostics Posts Anemic 1Q, and Our Fair Value Estimate Is Unchanged

      Commentary

      Thu, 24 Apr 2014

      Quest Diagnostics posted tepid first-quarter performance ..... the quarter to change our thinking on Quest 's narrow economic moat. Although the ..... these slightly more positive trends, Quest 's operating margin fell yet again

    10. Oakmark Equity and Income Fund Letter to Shareholders

      Headlines

      Tue, 8 Apr 2014

      t (Encana, Hospira and Quest Diagnostics ). Cimarex and Concho are oil and gas ..... position. In the case of Encana and Quest Diagnostics , fundamental underperformance ..... redeploy the money elsewhere. With Quest , its weakening market share and tougher

    « Prev12345Next »
    Content Partners